Albemarle — May 6, 2026 release

Adjusted EBITDA expanded in both Energy Storage (+196%) and Specialties (+30%). • Cash from operating activities of $346 million and free cash flow of $248 million (a) . Capital expenditures of $99 million; maintaining full-year capital expenditure forecast of $550 million to $600 million. • Delivered $40 million in cost and productivity improvements, on track to achieve full-year target of $100 million to $150 million. • Closed sales of Eurecat joint venture and controlling stake in Ketjen for a combined $648 million net cash proceeds. • Completed debt reduction actions that resulted in paying down $1.3 billion of outstanding debt and lowering the weighted average interest rate. • Improved 2026 outlook considerations, including increased full-year Specialties outlook for both sales and adjusted EBITDA, primarily due to higher prices, and reduced interest expense following recent debt reduction actions. Maintaining enterprise outlook scenarios as these improvements are expected to offset higher costs related to supply chain disruptions in the Middle East. (a)    See Non-GAAP Reconciliations for further details. “Albemarle had a strong start to 2026, with net sales and adjusted EBITDA up year over year. Higher pricing and volumes in Energy Storage and Specialties, along with continued cost and productivity actions, were the key contributors to our results,” said Kent Masters, Chairman and CEO. “We also took advantage of our successful cash and portfolio management a